NASDAQ · Analyst Forecast

GT Biopharma, Inc. (GTBP) Stock Forecast & Price Target

$3.18 NASDAQ: GTBP Market Cap $4.01M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering GT Biopharma, Inc. (GTBP), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For GT Biopharma, Inc., analysts forecast revenue rising from $13.50M in 2025 to $59.88M in 2030; the average estimate for 2030 earnings per share is $7.50; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$13.50M$13.50M$13.50M1
2026$9.70M$9.70M$9.70M1
2027$67.70M$67.70M$67.70M1
2028$0$0$01
2029$20.07M$20.07M$20.07M1
2030$59.88M$59.88M$59.88M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$41.50−$41.50−$41.501
2026−$10.75−$10.75−$10.751
2027−$8.00−$8.00−$8.001
2028−$7.00−$7.00−$7.001
2029$0.25$0.25$0.251
2030$7.50$7.50$7.501

GT Biopharma, Inc. (GTBP) forecast — frequently asked questions

What are analysts forecasting for GT Biopharma, Inc.'s earnings?

The average analyst estimate for GT Biopharma, Inc. (GTBP) earnings per share in 2030 is 7.50, with individual estimates between 7.50 and 7.50.

How much revenue is GT Biopharma, Inc. expected to make?

Analysts forecast GT Biopharma, Inc. (GTBP) revenue of $59.88M in 2030, based on 1 published estimates.

How many analysts cover GTBP?

1 analyst contribute estimates for GT Biopharma, Inc. (GTBP). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.